ECMO in patients with interstital lung diesease
What is it about?
The management of acute respiratory failure (ARF) in interstitial lung disease (ILD) is difficult. Intubation has been shown to be associated with a mortality rate of up to 90%. In current clinical practice, patients with ARF and ILD are generally not intubated and are given palliative care. Extracorporeal membrane oxygenation (ECMO) is viewed critically because the technology might not allow for the recovery of cardiopulmonary function.
Why is it important?
ECMO is a lifesaving option for patients with ILD and ARF provided they are suitable candidates for lung transplantation. In these cases, patients can undergo salvage Transplantation regardless of whether they have already been listed before ARF. ECMO is not able to reverse the poor prognosis in patients that do not qualify for lung transplantation.
The following have contributed to this page: Dr Philipp M Lepper and Franziska Trudzinski